Hemanext Overview
- Year Founded
-
2000
- Status
-
Private
- Employees
-
52
- Latest Deal Type
-
2ndary - Private
- Investors
-
8
Hemanext General Information
Description
Developer of transfusion medical technology designed to support the transfusion medicine community in efforts to save lives and improve patient outcomes. The company offers novel storage methods to potentially extend the shelf life of refrigerated red blood cells while enhancing the quality across the storage cycle, enabling healthcare providers to promote improvements in the quality, safety, and efficacy, and reduce the cost of transfusion therapy.
Contact Information
Website
hemanext.comCorporate Office
- 99 Hayden Avenue, Building B
- Suite 620
- Lexington, MA 02421
- United States
Corporate Office
- 99 Hayden Avenue, Building B
- Suite 620
- Lexington, MA 02421
- United States
Hemanext Timeline
Hemanext Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 23. Secondary Transaction - Private | 01-Feb-2026 | Completed | Generating Revenue | |||
| 22. Later Stage VC (Series C) | 04-Aug-2025 | Completed | Generating Revenue | |||
| 21. Later Stage VC (Series B3) | 22-Jul-2025 | Completed | Generating Revenue | |||
| 20. Later Stage VC (Series B2) | 01-Oct-2024 | Completed | Generating Revenue | |||
| 19. Later Stage VC (Series B1) | 05-Jan-2024 | Completed | Generating Revenue | |||
| 18. Later Stage VC (Series C) | 07-Feb-2023 | Completed | Generating Revenue | |||
| 17. Later Stage VC (Series B) | 07-Nov-2022 | Completed | Generating Revenue | |||
| 16. Later Stage VC | Completed | Generating Revenue | ||||
| 15. Later Stage VC (Series A) | 15-Oct-2021 | $48.4M | $82.8M | Completed | Generating Revenue | |
| 14. Debt - PPP | 16-Apr-2020 | $781K | $34.4M | Completed | Clinical Trials - General |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Hemanext Patents
Hemanext Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-D1084309-S1 | Combination spacer and oxygen indicator for blood storage device | Active | 09-Dec-2022 | ||
| US-D1084308-S1 | Spacer for blood storage device | Active | 09-Dec-2022 | ||
| EP-4604975-A1 | Treatment of blood transfusion-dependent patients with hematologic malignancies | Pending | 20-Oct-2022 | ||
| US-20260144821-A1 | Treatment of blood transfusion-dependent patients with hematologic malignancies | Pending | 20-Oct-2022 | ||
| WO-2024086835-A1 | Treatment of blood transfusion-dependent patients with hematologic malignancies | Inactive | 20-Oct-2022 | A61K35/14 |
Hemanext Signals
Hemanext Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Vitalant | Corporation | Minority | ||
| Antaeus Enterprises | Family Office | Minority | ||
| Eduardo Avayu Family Office | Family Office | Minority | ||
| Grabe Family Office | Family Office | Minority | ||
| Omega Advisors | Hedge Fund | Minority |
Hemanext FAQs
-
When was Hemanext founded?
Hemanext was founded in 2000.
-
Where is Hemanext headquartered?
Hemanext is headquartered in Lexington, MA.
-
What is the size of Hemanext?
Hemanext has 52 total employees.
-
What industry is Hemanext in?
Hemanext’s primary industry is Other Devices and Supplies.
-
Is Hemanext a private or public company?
Hemanext is a Private company.
-
What is Hemanext’s current revenue?
The current revenue for Hemanext is .
-
How much funding has Hemanext raised over time?
Hemanext has raised $220M.
-
Who are Hemanext’s investors?
Vitalant, Antaeus Enterprises, Eduardo Avayu Family Office, Grabe Family Office, and Omega Advisors are 5 of 8 investors who have invested in Hemanext.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process